Table 2 presents the associations between TGF-β1 concentrations in patients with early-onset CAD and clinical parameters, including history of diabetes, hypertension, presence of metabolic syndrome, myocardial infarction, impaired ventricular function, and left ventricular hypertrophy. Here, TGFB1 is linked to myocardial infarction.